Journal: bioRxiv
Article Title: Robust regulatory interplay of enhancers, facilitators, and promoters in a native chromatin context
doi: 10.1101/2025.07.07.663560
Figure Lengend Snippet: (A) NMU mRNA levels measured by RT-qPCR in single cell-derived recombinant clones; bars = median. Exact mutant sequences are listed in Table S1. (B–D) ChIP-qPCR of TF binding in select mutants: GATA1 (B) and RUNX1 (C) at e1; STAT5 (D) at e1 and e2 (n = 2 independent single cell clones per mutant). Statistical significance assessed using one-way ANOVA with Dunnett’s post hoc test vs. WT_eNMU (**, p < 0.01; ***, p < 0.001). Public ENCODE ChIP-seq tracks (fold change over control) shown as references: GATA1, ENCFF334KVR; RUNX1, ENCFF654QOE; STAT5A, ENCFF171KLX. (E) Left: p300 ChIP-seq profiles at the eNMU locus in the indicated mutants from (B–D); tracks represent merged biological replicates (n = 2). Track colors indicate specific motif disruptions: grey = WT_eNMU, green = e1_mRUNX1, red = e1_mGATA1, blue = e2_mSTAT5. Colored boxes below tracks indicate locations of disrupted TF motifs. Right: p300 signal at eNMU vs. NMU mRNA in matched single cell clones. (F) Schematic of regulatory factor interplay at eNMU. Note that, unlike normal physiological conditions where STAT5 proteins are activated in response to cytokine signaling, K562 cells express the constitutively active oncogenic BCR-ABL fusion protein that drives persistent STAT5 phosphorylation, dimerization and activation. , See also Methods.
Article Snippet: Parental wildtype K562 cells, an immortalized erythroleukemia cell line isolated from the bone marrow of a 53-year-old female patient with chronic myelogenous leukemia (CML), were obtained from the America Type Culture Collection (ATCC) (ATCC Number CCL-243) by the Yu lab and generously provided to us.
Techniques: Quantitative RT-PCR, Derivative Assay, Recombinant, Clone Assay, Mutagenesis, ChIP-qPCR, Binding Assay, ChIP-sequencing, Control, Phospho-proteomics, Activation Assay